Italy: Stevanato prices NY IPO at lower end of marketed range

Stevanato, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, priced its New York IPO of 32 million ordinary shares at a price of US$21 per share, raising US$672m in gross proceeds. Shares traded lower on its first day of trading, hitting a low of…

You must be a HMI Subscriber to view this content.

Subscribe Now »